SCAMP5 and Hyperglycemia: In this study, we demonstrate that SCAMP5 expression is reduced in β‐cells under diabetogenic situations, which is involved in hyperglycemia‐activated ChREBP‐mediated reduction of H3K4me3 at the Scamp5 promoter.